Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.
- Revenue: $58.89M. Running result $58.89M. Drug Discovery Contribution: $438K. Drug Discovery: $22.99M. Hosted Software: $15.15M. Maintenance: $4.88M. On Premise Software: $9.3M. Professional Services: $3.22M. Software Contribution: $2.92M.
- Cost of revenue: −$26.46M. Running result $32.43M.
- Gross profit: $32.43M. Running result $32.43M.
- Research and development: −$41M. Running result −$8.57M.
- Sales and marketing: −$10.27M. Running result −$18.83M.
- General and administrative (includes related party expense of $165, $109, $330 and $218): −$22.72M. Running result −$41.55M.
- Operating income: −$41.55M. Running result −$41.55M.
- Other income: $48.89M. Running result $7.35M.
- Pre-tax income: $7.35M. Running result $7.35M.
- Income tax expense: −$1.37M. Running result $5.98M.
- Net income: $5.98M. Running result $5.98M.
